Article Information
History
- April 8, 2020.
Article Versions
- You are currently viewing Version 1 of this article (April 8, 2020 - 03:21).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- John P.A. Ioannidis, MD, DSc1,2,*,
- Cathrine Axfors, MD, PhD2,3 and
- Despina G. Contopoulos-Ioannidis, MD4
- 1Stanford Prevention Research Center, Department of Medicine, and Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA
- 2Meta-Research Innovation Center at Stanford (METRICS), Stanford, California, USA
- 3Department of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden
- 4Division of Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA
- ↵*Correspondence to: John P.A. Ioannidis, MD, DSc, Stanford Prevention Research Center, 1265 Welch Road, Medical School Office Building, Room X306, USA. E-mail: jioannid{at}stanford.edu
Posted April 08, 2020.
Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters
